Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-29, Stock:ABT, The news for the past five days is as follows:
2018-05-21: NEWS1: The Performance of Roche’s Diagnostics Division in Q1 2018.NEWS2: Shocking the Spine Offers an Alternative to Opioids.
2018-05-22: NEWS1: Cardiovascular Systems Rides on New Products Amid Tight Race.NEWS2: Cardiovascular Systems Rides on New Products Amid Tight Race.NEWS3: Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions.NEWS4: Abbott Reports Five-year Results From FAME 2 Study - Quick Facts.NEWS5: Abbott Reports Five-year Results From FAME 2 Study - Quick Facts.
2018-05-23: NEWS1: Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease.NEWS2: Abbott's Investigational Tendyne™ Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study.
2018-05-24: NEWS1: OEF, ABT, UTX, CAT: ETF Outflow Alert.NEWS2: OEF, ABT, UTX, CAT: ETF Outflow Alert.NEWS3: Abbott Gets FDA Nod for XIENCE Sierra, To Boost Vascular Wing.NEWS4: Abbott Gets FDA Nod for XIENCE Sierra, To Boost Vascular Wing.NEWS5: Abbott Gets FDA Nod for XIENCE Sierra, To Boost Vascular Wing.NEWS6: Abbott Labs and Three Additional Medical Equipment Stocks on Our Research Desk’s Radar.
2018-05-25: NEWS1: How to Invest in Diabetes Stocks.NEWS2: How to Invest in Diabetes Stocks.NEWS3: How to Invest in Diabetes Stocks.NEWS4: A Focus on Eye Care Is Setting Up Johnson & Johnson Stock for the Future.NEWS5: A Focus on Eye Care Is Setting Up Johnson & Johnson Stock for the Future.NEWS6: S&P 500 Analyst Moves: ABT.NEWS7: S&P 500 Analyst Moves: ABT.NEWS8: Five Top MedTech Stocks in Diabetes.NEWS9: Five Top MedTech Stocks in Diabetes.NEWS10: Abbott Presents Positive Study Results for Tendyne Device.NEWS11: Abbott Presents Positive Study Results for Tendyne Device.NEWS12: Top Stock Reports for Duke Energy, Charter Communications & Abbott.NEWS13: Five Top MedTech Stocks in Diabetes.NEWS14: A Focus on Eye Care Is Setting Up Johnson & Johnson Stock for the Future.NEWS15: Abbott Presents Positive Study Results for Tendyne Device.

Answer: Decrease